Congenital Brachyesophagus-Intrathoracic Stomach-Vertebral Anomalies Syndrome

Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome is an ultra-rare birth defect syndrome. It is also called a rare syndromic esophageal malformation. In this condition, the food pipe, called the esophagus, is abnormally short from birth. Because it is too short, the stomach is pulled or kept high inside the chest instead of staying in the abdomen. At the same time, there are important spine defects, especially in the neck and upper chest area. Reported cases also show other body problems such as a midline diaphragmatic hernia, short neck, poor growth before birth, bowel malrotation, herniation of other abdominal organs, splenic abnormalities, and cleft lip. The disorder often starts before birth and is usually very serious. Published reports say many affected babies die before birth, in the newborn period, or in early infancy, although a small number have survived longer with major medical and surgical care. 1 2 3 4

Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome is an ultra-rare birth disorder. In simple words, the food pipe is abnormally short from birth, the stomach moves up into the chest, and there are vertebral or spinal defects, often with other malformations such as diaphragmatic hernia, growth restriction, malrotation, or herniation of other organs. Reports from Orphanet, GARD, and case literature show that it is usually very severe and may be fatal in the newborn or early infant period, so treatment is mainly supportive, surgical, and individualized in expert pediatric centers rather than based on one single standard drug plan.

Another names

Doctors have used a few names for the same syndrome. The main names are congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome, congenital brachyesophagus, intrathoracic stomach, vertebral anomalies syndrome, and serpentine-like syndrome. The “serpentine-like” name came from the comparison with snake anatomy, because snakes normally have a thoracic stomach and different vertebral structure. 1 2 3

Types in list view

There are no officially established types of this syndrome in the medical literature. Because the condition is so rare, doctors usually describe cases by how severe they are and which extra organs are involved, not by fixed subtype names. 1 2

• Prenatal lethal form. Some fetuses are diagnosed during pregnancy and die before birth or the pregnancy is ended because the abnormalities are very severe. 1 2
• Severe neonatal form. Many babies are born alive but become critically ill soon after birth because of breathing, feeding, and major structural problems. 1 2
• Survivable operated form. A few children have survived after repeated surgery, airway support, and long-term feeding support. 1
• Form with major extra-organ anomalies. Some reported patients also had spleen, bowel, lip, brain, or other abdominal organ defects. 1 2
• Variant or overlap form. Some case reports look very similar but not every patient has exactly the same combination of defects. 1 2

20 causes

Because this syndrome is extremely rare, 20 separate proven causes have not been established. The direct cause is still unknown. GARD says the disease is caused by a change in genetic material, and published case reviews say a shared molecular cause is suspected but not yet identified. So the list below gives reported or proposed causes and developmental mechanisms, not fully proven causes. 1 2

• Pathogenic DNA change. Rare-disease databases describe the disorder as genetic, meaning a harmful DNA change is the most likely root cause. 1
• New spontaneous mutation. Reported cases are usually sporadic, so a new mutation arising early in development is possible. 1
• Inherited mutation in some families. GARD notes that genetic mutations can sometimes be inherited, even though family patterns are not yet clear for this syndrome. 1
• Defect in early foregut development. The very short esophagus suggests abnormal growth of the foregut in early embryonic life. 1 2
• Failure of normal esophageal elongation. The syndrome’s core defect is congenital brachyesophagus, meaning the esophagus does not reach normal length. 1
• Abnormal diaphragmatic development. Several reports describe a midline diaphragmatic hernia or diaphragmatic dysplasia, which can help the stomach move into the chest. 1 2
• Abnormal fixation of the stomach. Poor attachment or support of the stomach may contribute to intrathoracic position in some cases. 1 2
• Abnormal vertebral segmentation. The spine defects point to disturbed early vertebral patterning and segmentation. 1
• Rachischisis or spinal dysraphism. Open or split spinal structures are cardinal features in many patients and likely reflect a very early developmental defect. 1 2
• Abnormal cervical-thoracic spine formation. Many cases especially involve the neck and upper chest spine, showing that this region may be especially affected during development. 1
• Possible homeobox or developmental pathway defect. One review suggested a common molecular cause may involve developmental “toolkit” or homeobox genes, but this remains a hypothesis. 1
• Multisystem embryologic error. The syndrome affects the foregut, diaphragm, spine, spleen, and bowel, so the likely problem happens very early and affects more than one body system. 1
• Abnormal spleen development. Reports of asplenia, polysplenia, or splenic malposition suggest disturbed left-right or upper abdominal organ development may play a role. 1 2
• Abnormal bowel rotation. Malrotated gut is often described, suggesting failure of normal intestinal rotation in fetal life. 1
• Herniation of other abdominal organs. In some cases not only the stomach but also other abdominal organs move upward, showing a broader structural development problem. 1
• Abnormal midline development. Midline diaphragmatic defects and median cleft lip in some cases suggest disturbed midline formation. 1
• Possible neural tube development defect. Some reports include rachischisis and encephalocele, which support involvement of early neural tube development. 1
• Abnormal trachea-esophagus relationship. Some prenatal reports raised concern for esophagobronchial fistula or other foregut separation problems. 1
• Abnormal lung development secondary to chest organ displacement. When the stomach fills the chest, lung growth may be reduced, worsening the condition. 1
• Unknown molecular cause. Even after karyotype, microarray, or genome testing, some cases show no clear answer, so the final cause remains unknown in many patients. 1 2

15 symptoms

Symptoms can begin before birth or just after birth. In this syndrome, many “symptoms” are actually visible structural abnormalities plus problems with breathing and feeding. Not every baby has every feature. 1 2

• Intrathoracic stomach. The stomach sits in the chest, and this is one of the main defining findings. 1
• Very short esophagus. The food pipe is too short from birth, which pulls the stomach upward. 1
• Neck and upper spine abnormality. Many babies have cervical or thoracic rachischisis, scoliosis, or vertebral deformity. 1 2
• Short neck. This is often noted in reported babies. 1
• Poor growth before birth. Intrauterine growth restriction has been described in several reports. 1 2
• Breathing trouble. Chest crowding, lung underdevelopment, and airway problems can cause respiratory distress. 1 2
• Feeding difficulty. Babies may not feed safely by mouth and often need tube feeding. 1
• Vomiting or poor stomach emptying. Foregut abnormality can cause obstruction-like symptoms. 1
• Reflux. Abnormal stomach position and short esophagus can promote severe reflux. 1
• Bowel malrotation. The intestines may be in the wrong position. 1
• Herniation of other organs. Spleen, bowel, pancreas, or duodenum may also be displaced into the chest. 1
• Splenic abnormality. Some patients have asplenia, polysplenia, or malpositioned spleen. 1 2
• Cleft lip. Median cleft lip has been reported in some babies. 1
• Pleural effusion or small lungs. Some prenatal cases show fluid around the lung and right lung dysplasia. 1
• Very poor overall prognosis. This is not a symptom felt by the baby, but it is an important clinical feature because many cases are fatal very early. 1 2

20 diagnostic tests

Doctors diagnose this syndrome by combining physical examination, bedside manual assessment, lab and pathology work, electrodiagnostic support tests, and imaging. Imaging is the most important part because it shows the short esophagus, stomach in the chest, diaphragm problem, and spine defects. 1 2

Physical exam

1. General newborn physical exam. The doctor looks at breathing, color, posture, body shape, and overall stability. 1
2. Airway and chest exam. The doctor checks for fast breathing, low air entry, chest asymmetry, and distress. 1
3. Neck and spine exam. This may show short neck, visible spinal defect, or abnormal curvature. 1
4. Abdominal exam. Doctors check whether the abdomen looks scaphoid or unusually empty when organs are displaced upward. 1

Manual bedside tests

5. Growth measurement. Weight, length, and head size help detect intrauterine growth restriction and postnatal growth problems. 1
6. Bedside feeding assessment. Clinicians observe sucking, swallowing, coughing, gagging, and feed tolerance. 1
7. Neurologic bedside exam. This helps look for movement problems or signs of major spine and neural tube involvement. 1
8. Manual spine stability assessment. Specialists carefully assess cervical alignment and instability risk. 1

Lab and pathological tests

9. Complete blood count. This checks infection, anemia, and general illness severity. 1
10. Blood gas test. This shows how badly breathing trouble is affecting oxygen and carbon dioxide levels. 1
11. Karyotype. Chromosome analysis has been used to look for large chromosomal abnormalities. 1
12. Chromosomal microarray. This checks for smaller copy number changes when karyotype is normal. 1
13. Whole exome or whole genome testing. Advanced genetic testing may be used, although some cases still show no answer. 1
14. Autopsy or surgical pathology. In fatal or operated cases, direct tissue and organ examination has confirmed the diagnosis. 1 2

Electrodiagnostic tests

15. Electrocardiogram. This is not specific for the syndrome, but it is used to assess heart rhythm and overall stability in sick newborns. 1
16. Continuous cardiorespiratory and pulse-oximetry monitoring. This supportive bedside monitoring helps detect apnea, low oxygen, and instability. 1

Imaging tests

17. Prenatal 2D ultrasound. This is often the first test to show a chest cystic structure, missing stomach bubble in the abdomen, or suspected diaphragmatic problem. 1
18. Prenatal 3D ultrasound. This can improve spatial detail and help show multiorgan malformations more clearly. 1
19. Fetal MRI. MRI helps define the short esophagus, stomach position, diaphragm, lungs, and spine more clearly before birth. 1 2
20. Postnatal chest X-ray and upper GI contrast study. Chest X-ray may show an abnormal air-fluid structure in the chest, while contrast study can confirm the intrathoracic stomach and short esophagus. Spine MRI or CT may then be added to define the vertebral defect. 1 2 3

This syndrome is a very rare and very serious birth defect pattern. The core problem is a very short esophagus, a stomach placed in the chest, and major vertebral defects, especially in the cervical and thoracic spine. Other organs can also be abnormal. The true molecular cause is still not fully known, although a genetic cause is suspected. Diagnosis depends mostly on prenatal ultrasound, fetal MRI, postnatal imaging, careful physical examination, and genetic testing. Because there are very few published cases, doctors must often use case reports and expert judgment when caring for affected babies. 1 2 3

Non-pharmacological treatments

1. NICU stabilization means careful control of breathing, warmth, fluids, and oxygen right after birth. Its purpose is to keep the baby alive and stable. The mechanism is basic organ support while specialists plan imaging and surgery.
2. Multidisciplinary care uses pediatric surgery, neonatology, gastroenterology, nutrition, radiology, orthopedics, and genetics together. Its purpose is safer decision-making in a complex birth disorder. The mechanism is coordinated care for many organs at the same time.
3. Prenatal ultrasound follow-up can help detect an absent stomach bubble or chest cystic structure before birth. Its purpose is early planning. The mechanism is earlier recognition of abnormal stomach position and short esophagus.
4. Upper GI contrast study is often used after birth to define anatomy. Its purpose is to show where the stomach is and how the esophagus is shaped. The mechanism is contrast imaging of the swallowing tract.
5. Chest and abdominal X-ray helps find intrathoracic stomach and abnormal gas pattern. Its purpose is quick screening. The mechanism is rapid visualization of air-filled structures in chest and abdomen.
6. Jejunal or transpyloric feeding may be used when reflux is severe and stomach feeding is unsafe. Its purpose is nutrition with less reflux burden. The mechanism is feeding beyond the stomach.
7. Nasogastric decompression can reduce pressure and vomiting in selected babies. Its purpose is symptom relief and aspiration reduction. The mechanism is removal of swallowed air and stomach contents.
8. Positioning therapy means careful head elevation and safe posture after feeds when advised by the care team. Its purpose is to reduce reflux symptoms. The mechanism is less backward movement of stomach contents.
9. Thickened or adjusted feeding plans may help some children with reflux symptoms, but only under specialist guidance. Its purpose is feeding tolerance. The mechanism is changing feed volume, timing, and texture.
10. Swallow and feeding therapy helps babies or children who gag, choke, or refuse food. Its purpose is safer oral feeding. The mechanism is oral-motor training and paced feeding strategies.
11. Growth monitoring checks weight, length, and hydration very closely. Its purpose is to catch failure to thrive early. The mechanism is repeated nutritional assessment with fast adjustment of calories.
12. Aspiration prevention care includes suction readiness, slow feeding, and fast response to cough or choking. Its purpose is lung protection. The mechanism is lowering entry of feed or reflux into the airway.
13. Respiratory support may include oxygen, CPAP, or ventilation in severe newborn cases. Its purpose is to support breathing when the chest organs are compressed or the baby aspirates. The mechanism is assisted gas exchange.
14. Genetic counseling helps families understand rarity, uncertainty, and recurrence questions. Its purpose is informed family planning. The mechanism is review of family history and available genetic testing.
15. Spinal and orthopedic assessment is important because vertebral defects can affect posture, neck movement, and future growth. Its purpose is early detection of skeletal problems. The mechanism is exam plus imaging and follow-up.
16. Endoscopic follow-up may be needed later if reflux damage, ulceration, or swallowing trouble is suspected. Its purpose is to detect complications. The mechanism is direct visualization of the esophagus and stomach.
17. Long-term reflux surveillance is needed in survivors. Its purpose is to find esophagitis, poor growth, and feeding problems early. The mechanism is regular follow-up with GI and surgery teams.
18. Family training for home care teaches warning signs, feeding methods, and medicine timing. Its purpose is safer daily care. The mechanism is reducing delay when symptoms worsen.
19. Psychological support for parents is important because this syndrome is very rare and often severe. Its purpose is to reduce stress and improve caregiving ability. The mechanism is counseling and practical support.
20. Early referral to a pediatric surgical center is one of the most important non-drug treatments. Its purpose is access to imaging, intensive care, and complex reconstruction. The mechanism is expert, staged management in a high-risk congenital anomaly.

Drug treatments actually used for complications

There is no FDA-approved drug that cures this syndrome itself. The most relevant medicines are used for acid reflux, esophagitis, vomiting, pain, and infections. The strongest disease-related support is for acid suppression in complicated pediatric reflux, especially erosive esophagitis.

1. Omeprazole is a proton pump inhibitor. FDA labeling supports use for pediatric GERD and erosive esophagitis; pediatric dosing in the label is weight-based, such as 5 mg daily for 5 to under 10 kg, 10 mg daily for 10 to under 20 kg, and 20 mg daily above 20 kg in children 1 to 16 years. It is usually given before food. Purpose: reduce acid injury. Mechanism: blocks the gastric acid pump. Side effects can include headache, abdominal pain, diarrhea, and long-term safety concerns if used without review.
2. Famotidine is an H2 blocker. FDA labeling supports pediatric GERD treatment, including in infants and older children. Purpose: reduce acid when PPIs are unsuitable or unavailable. Mechanism: blocks histamine-2 receptors in stomach cells and lowers acid secretion. Side effects may include headache, constipation, diarrhea, or dose adjustment needs in kidney disease.
3. Esomeprazole is another proton pump inhibitor. FDA labeling supports short-term treatment of acid-mediated GERD and erosive esophagitis in pediatric age groups. Purpose: heal inflamed esophagus and reduce pain or vomiting from acid reflux. Mechanism: suppresses the final step of acid production. Side effects are similar to omeprazole.
4. Lansoprazole is also a proton pump inhibitor. FDA labeling supports short-term treatment of symptomatic GERD and erosive esophagitis in children 1 to 17 years, but evidence in infants is weaker. Purpose: acid suppression. Mechanism: proton pump inhibition. Side effects include diarrhea, abdominal pain, and possible overuse problems if continued without reassessment.
5. Pantoprazole may be used for erosive esophagitis associated with GERD in children. Purpose: lower acid exposure when esophageal injury is present. Mechanism: proton pump inhibition. Side effects are similar to other PPIs. Pediatric treatment beyond the labeled duration needs specialist review.
6. Baclofen is not a cure and is not first-line, but pediatric GERD guidelines say it may be considered before surgery in selected refractory cases. Purpose: reduce transient lower esophageal sphincter relaxations and reflux episodes. Mechanism: GABA-B receptor activity. Side effects include sleepiness, weakness, and dizziness.
7. Metoclopramide is sometimes discussed for poor gastric emptying, but major pediatric GERD guidelines suggest not using it routinely for GERD because benefit is limited and adverse effects can be important. Purpose in rare selected cases: improve motility. Mechanism: dopamine antagonism with prokinetic action. Side effects may include drowsiness, irritability, and extrapyramidal reactions.
8. Ondansetron does not treat the malformation, but it may be used around surgery or for severe vomiting in selected hospital situations. FDA labeling supports nausea and vomiting indications, especially postoperative settings. Purpose: symptom control. Mechanism: 5-HT3 receptor blockade. Side effects can include headache, constipation, and QT-related rhythm caution in susceptible patients.
9. Sucralfate is not disease-specific and is mainly an ulcer-protective agent. In selected esophageal irritation cases, specialists may sometimes use mucosal protective therapy, though this syndrome-specific evidence is weak. Purpose: coat injured mucosa. Mechanism: forms a protective barrier on damaged tissue. Side effects may include constipation.
10. Antibiotics are not routine treatment for the syndrome itself, but they become important if aspiration pneumonia, postoperative infection, or line infection occurs. Purpose: treat proven infection. Mechanism: depends on the chosen antibiotic and culture results. Side effects vary by drug, so they must be selected by the hospital team.

Dietary molecular supplements

Supplements do not fix the short esophagus or intrathoracic stomach. They are only supportive when growth is poor, feeding is limited, or blood tests show deficiency.

1. Iron may be used if anemia develops from poor intake or chronic inflammation.
2. Vitamin D may help bone health, especially in low intake or limited growth.
3. Calcium may be needed when nutrition is poor.
4. Zinc may support growth and wound healing if deficient.
5. Multivitamin drops may be used in infants with restricted intake.
6. Vitamin B12 may be added if deficiency is proven.
7. Folate may help if folate deficiency exists.
8. Protein modular supplements may raise calorie and protein intake.
9. Medium-chain triglyceride formulas may be used in selected feeding plans.
10. Oral rehydration support may help during vomiting or poor intake. All supplement doses should be individualized by age, weight, lab values, and feeding route; there is no syndrome-specific supplement protocol.

Immunity booster, regenerative, and stem-cell drugs

At present, there is no proven immunity booster, regenerative medicine, or stem-cell drug approved specifically for congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome. Stem-cell therapy is not standard care for this condition, and using the phrase “immunity booster” can be misleading because the main problem is structural anatomy, not a weak immune system. In real practice, treatment focuses on surgery, nutrition, reflux control, airway safety, and infection treatment when needed.

Surgeries

1. Reduction of the intrathoracic stomach moves the stomach back toward the abdomen. It is done to improve anatomy, feeding, and breathing.
2. Diaphragmatic or hiatal repair closes the defect that allows abdominal organs to move into the chest. It is done to prevent re-herniation and organ compression.
3. Fundoplication may be considered for severe reflux that does not improve with careful medical and feeding management. It is done to reduce reflux and aspiration risk.
4. Gastrostomy or transgastric jejunostomy creates longer-term feeding access when safe oral intake is not possible. It is done to support nutrition and bypass severe feeding failure.
5. Complex esophageal reconstruction or replacement may be needed in selected survivors when the native esophagus is too short or malformed for normal function. It is done only in highly specialized centers.

Prevention points

Because this is a congenital malformation, there is no guaranteed prevention. These points are best seen as risk-reduction steps before and during pregnancy: preconception folic acid, control of diabetes, avoidance of alcohol and smoking, review of prescription drugs with a doctor, avoidance of known teratogens, good prenatal nutrition, early antenatal care, detailed anomaly ultrasound, genetic counseling if there is family history, and delivery planning at a tertiary center when a major anomaly is suspected. These steps may reduce some birth-defect risks or improve preparation, but they cannot promise prevention of this exact syndrome.

When to see doctors urgently

Seek urgent medical care for repeated vomiting, green vomit, choking during feeds, breathing difficulty, blue lips, fever, poor urine output, blood in vomit or stool, severe abdominal swelling, failure to gain weight, or signs of dehydration. Survivors also need regular follow-up with pediatric surgery and gastroenterology because reflux, feeding disorders, dysphagia, and poor growth may continue over time.

Food tips: what to eat and what to avoid

For babies and children who can feed, the best “foods” depend on age and anatomy. In general, use the feeding plan recommended by the pediatric team: breast milk or age-appropriate formula, smaller frequent feeds, calorie-dense feeds if growth is poor, iron-rich foods when age-appropriate, protein-rich soft foods, and textures approved by a swallow therapist. Avoid force feeding, very large feeds, foods that clearly worsen reflux, lying flat right after feeding, and any homemade supplement plan without medical review. In severe cases, tube feeding may be safer than normal eating.

FAQs

1. Is this syndrome common? No. It is extremely rare, with only a small number of cases reported.

2. Is it genetic? GARD lists it as caused by a change in genetic material, but the exact cause is still not fully defined.

3. Does it always affect the spine? Vertebral or spinal anomalies are a key part of the syndrome, especially cervical or thoracic defects.

4. Can medicine cure it? No. Medicines only treat complications such as reflux, pain, vomiting, or infection.

5. Is surgery usually needed? Often yes, because the main problem is abnormal anatomy.

6. Is reflux common? Yes, reflux-related problems are a major concern in children with severe esophageal malformations.

7. Can the baby have feeding problems? Yes. Poor feeding, vomiting, aspiration, and poor growth are common concerns.

8. Can it be seen before birth? Sometimes yes, by prenatal ultrasound.

9. Is the outlook always poor? Many reported cases were severe, but recent case literature shows some longer survival is possible with complex care.

10. Are stem cells a standard treatment? No. There is no approved stem-cell therapy for this syndrome.

11. What is the best drug for reflux? PPIs are usually the main medicines when erosive reflux disease is present, under specialist supervision.

12. Are H2 blockers useful? Yes, sometimes, especially when PPIs cannot be used.

13. Should metoclopramide be used routinely? No. Guidelines advise against routine use for pediatric GERD.

14. Who should manage these children? A tertiary pediatric center with surgery, GI, NICU, and nutrition support.

15. Can adults live with related anatomy? Rarely, yes; unusual survivor cases have been reported, but they remain exceptional.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: March 12, 2025.